XML 59 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value - Additional Information (Details)
$ in Thousands
 1 Months Ended 12 Months Ended
Jul. 31, 2023
USD ($)
Installment
Apr. 07, 2022
Jan. 01, 2022
USD ($)
Oct. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
Installment
Apr. 30, 2024
USD ($)
Installment
Apr. 30, 2022
USD ($)
Installment
Dec. 31, 2023
USD ($)
Installment
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2018
USD ($)
Installment
shares
Nov. 21, 2022
shares
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Change in fair value of warrant liability               $ 1,274 $ (84)    
2018 Notes | Series G Preferred Stock                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Warrant issued to purchase shares | shares               613,333      
Contingent Consideration                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Interest expense due to passage of time and fixed payment schedule               $ 3,900 3,100    
Warrant Liabilities                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Warrant issued to purchase shares | shares                     5,000,000
Change in fair value of warrant liability               $ (1,300) $ 100    
Integrated Diagnostics, Inc | Contingent Consideration                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business acquisition description               requires additional consideration to be paid by the Company to such shareholders upon attainment of a three-consecutive month      
Business acquisition contingent consideration gross margin target                   $ 2,000  
Business acquisition contingent consideration gross margin target period                   7 years  
Integrated Diagnostics, Inc | Contingent Consideration | Third Amendment to APA Agreement                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Contingent consideration number of installments | Installment 3           5        
Milestone payment $ 3,000           $ 2,000        
Percentage of interest on installment payments   10.00%                  
Integrated Diagnostics, Inc | Contingent Consideration | Scenario Forecast | Third Amendment to APA Agreement                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Contingent consideration number of installments | Installment         1 1          
Milestone payment         $ 8,400 $ 5,000          
Exit fee payment       $ 6,100              
Integrated Diagnostics, Inc | Common Stock | Contingent Consideration                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business acquisition description               If Indi elected to not exercise its option, the Company had 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.      
Contingent consideration shares | shares                   2,520,108  
Contingent consideration number of installments | Installment               6   8  
Contingent consideration arrangements, common shares, redemption amount     $ 4,600             $ 37,000  
Repayments of debt 9,300                    
Business combination contingent consideration final payment $ 37,000                    
Contingent consideration cash payment                   $ 37,000  
Investment, Type [Extensible Enumeration]                   Repurchase  
Integrated Diagnostics, Inc | Common Stock | Contingent Consideration | Repurchase                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Contingent consideration number of installments | Installment                   2  
Minimum | Contingent Consideration                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range               11.00%      
Maximum | Contingent Consideration                      
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range               16.00%